Table 3 Liver fibrosis stage at HCV diagnosis and pre-treatment initiation.
From: A cascade of care analysis on the elimination of hepatitis C from public hospitals in Madrid
Haemodialysis n (%) | HIV n (%) | PWID n (%) | HHD n (%) | ALD n (%) | Transplant n (%) | Total n (%) | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liver fibrosis stage | Diagnosis (n = 46) | Pre-TI (n = 45) | Diagnosis (n = 237) | Pre-TI (n = 235) | Diagnosis (n = 122) | Pre-TI (n = 121) | Diagnosis (n = 6) | Pre-TI (n = 3) | Diagnosis (n = 285) | Pre-TI (n = 281) | Diagnosis (n = 163) | Pre-TI (n = 157) | Diagnosis (n = 859) | Pre-TI (n = 842) |
F0 | 6 (13.0) | 5 (11.1) | 31 (13.1) | 30 (12.8) | 47 (38.5) | 45 (37.2) | 0 (0.0) | 0 (0.0) | 2 (0.7) | 1 (0.4) | 4(2.5) | 20(12.7) | 90 (10.5) | 101 (12.0) |
F0–F1 | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.6) | 2 (1.7) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.2) | 2 (0.2) |
F1 | 12 (26.1) | 10 (22.2) | 60 (25.3) | 49 (20.9) | 22 (18.0) | 26 (21.5) | 0 (0.0) | 0 (0.0) | 31 (10.9) | 27 (9.6) | 3 (1.8) | 4 (2.5) | 128 (14.9) | 116 (13.8) |
F2 | 6 (13.0) | 6 (13.3) | 33 (13.9) | 32 (13.6) | 6 (4.9) | 9 (7.4) | 1 (16.7) | 1 (33.3) | 22 (7.7) | 21 (7.5) | 8 (4.9) | 11 (7.0) | 76 (8.8) | 80 (9.5) |
F3 | 7 (15.2) | 6 (13.3) | 28 (11.8) | 28 (11.9) | 10 (8.2) | 9 (7.4) | 1 (16.7) | 0 (0.0) | 36 (12.6) | 37 (13.2) | 13 (8.0) | 14 (8.9) | 95 (11.1) | 94 (11.0) |
F4 | 12 (26.1) | 15 (33.3) | 75 (31.6) | 91 (38.7) | 19 (15.6) | 19 (15.7) | 3 (50.0) | 2 (66.7) | 190 (66.7) | 193 (68.7) | 133 (81.6) | 108 (68.8) | 432 (50.3) | 428 (50.9) |
No data | 3 (6.5) | 3 (6.7) | 10 (4.2) | 5 (2.1) | 16 (13.1) | 11 (9.1) | 1 (16.7) | 0 (0.0) | 4 (1.4) | 2 (0.7) | 2 (1.2) | 0 (0.0) | 36 (4.2) | 21 (2.5) |
